A novel human iPSC model of COL4A1/A2 small vessel disease unveils a key pathogenic role of matrix metalloproteinases. (2023)
Attributed to:
Joint Wellcome and MRC Centre, ‘Wellcome Trust – Medical Research Council Cambridge Stem Cell Institute’
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.stemcr.2023.10.014
PubMed Identifier: 37977146
Publication URI: http://europepmc.org/abstract/MED/37977146
Type: Journal Article/Review
Volume: 18
Parent Publication: Stem cell reports
Issue: 12
ISSN: 2213-6711